In 2023, the community pharmacy market in Belgium stood at 44.5 units in volume of generics.

From 2013 to 2023, the market exhibited generally consistent growth, transitioning from year-on-year variations of 4-6% in the earlier years to around 1-2% in the most recent years. Over the last five years, the compound annual growth rate (CAGR) averaged 1.95%, highlighting a deceleration compared to the earlier periods of analysis.

Looking forward, the forecasted values indicate continued, albeit modest, growth with a projected annual average increase of 1.08% up to 2028.

Future trends to watch for:

Impact of governmental healthcare policies on generic drug consumption.
Shifts in population demographics, such as aging, affecting the demand for generic medications.
Technological advancements and digital health integration into community pharmacies.
Economic factors influencing overall healthcare expenditure.